Medication info

Tobramycin Injection 80mg (Tobramycin)

Prescription medicationIntramuscular injection · Intravenous injection
Ingredient · strength
Tobramycin›40mg / 1mL
Manufacturer / importer
Kookje Pharmaceutical Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid contained in a colorless transparent ampoule
Packaging
2mL-50 ampoules per box
Approval status
Active

MFDS item code 201804937 · Notified 2018.12.06 · Insurance code 643704661

Summary

Main use
Treatment of systemic and organ infections (such as sepsis and pneumonia), and skin, soft-tissue, and bone infections
Who receives it
Adults · Children
Adult administration
For severe infections, administer tobramycin 3mg (potency)/kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency)/kg of body weight per day may be administered in 3~4 divided doses; reduce the dose to 3mg (potency)/kg of body weight per day when symptoms improve. Do not administer more than 5mg (potency)/kg of body weight per day without measuring serum concentrations. Measure the serum concentration of this medicine if possible. After administering an initial dose of 1mg (potency)/kg of body weight, reduce the dose or extend the dosing interval starting with the second dose. If the serum concentration of this medicine cannot be measured directly, calculate it based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, do not use these methods during dialysis. Dose reduction (8-hour dosing interval): If creatinine clearance is 70mL/min or less, or the serum creatinine concentration is known, calculate the dose by multiplying the dose for a patient with normal renal function by the corresponding percentage in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for a patient with normal renal function by the serum creatinine concentration. Extended dosing interval (same dose as in patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer doses at intervals, in hours, calculated by multiplying the serum creatinine concentration by 6. The dose may be adjusted as appropriate according to age and symptoms. For intramuscular injection, dissolve in 1.5mL of physiological saline injection or water for injection. For intravenous administration in adults, dilute the dose in 50~100mL of physiological saline injection or 5% dextrose injection and administer by intravenous infusion over 20~60 minutes. Avoid intravenous infusion over less than 20 minutes, as the serum tobramycin concentration may exceed 12μg/mL; it is preferable not to mix this medicine with other medicines.
Child administration
Children: Administer 6~7.5mg (potency)/kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Neonates (less than 1 week old): Administer 4mg (potency)/kg of body weight per day in divided doses every 12 hours. For children, reduce the volume of diluent proportionally.

Ingredients

Manufacturer
Kookje Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of systemic and organ infections (such as sepsis and pneumonia), and skin, soft-tissue, and bone infections

  • Meningitis
  • central nervous system infections
  • bronchitis
  • bronchiectasis
  • pneumonia
  • peritonitis
  • gastrointestinal infections
  • subcutaneous abscess
  • boils
  • soft tissue inflammation
  • burns
  • post-surgical wound infections
View approved original text

This medication is effective against a variety of bacteria including Pseudomonas, Proteus, Escherichia coli, and Klebsiella. It is used for the treatment of meningitis, a central nervous system infection, and is also effective for respiratory infections such as bronchitis, bronchiectasis, and pneumonia. Additionally, it helps treat gastrointestinal infections like peritonitis as well as skin and soft tissue infections, burns, and post-surgical wound infections. It is also utilized in the treatment of osteomyelitis and sepsis, and for urinary infections such as pyelonephritis and cystitis. This drug targets various bacterial infections and helps improve patient conditions.

How it is given

Adult administration

For severe infections, administer tobramycin 3mg (potency)/kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency)/kg of body weight per day may be administered in 3~4 divided doses; reduce the dose to 3mg (potency)/kg of body weight per day when symptoms improve. Do not administer more than 5mg (potency)/kg of body weight per day without measuring serum concentrations. Measure the serum concentration of this medicine if possible. After administering an initial dose of 1mg (potency)/kg of body weight, reduce the dose or extend the dosing interval starting with the second dose. If the serum concentration of this medicine cannot be measured directly, calculate it based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, do not use these methods during dialysis. Dose reduction (8-hour dosing interval): If creatinine clearance is 70mL/min or less, or the serum creatinine concentration is known, calculate the dose by multiplying the dose for a patient with normal renal function by the corresponding percentage in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for a patient with normal renal function by the serum creatinine concentration. Extended dosing interval (same dose as in patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer doses at intervals, in hours, calculated by multiplying the serum creatinine concentration by 6. The dose may be adjusted as appropriate according to age and symptoms. For intramuscular injection, dissolve in 1.5mL of physiological saline injection or water for injection. For intravenous administration in adults, dilute the dose in 50~100mL of physiological saline injection or 5% dextrose injection and administer by intravenous infusion over 20~60 minutes. Avoid intravenous infusion over less than 20 minutes, as the serum tobramycin concentration may exceed 12μg/mL; it is preferable not to mix this medicine with other medicines.

Child administration

Children: Administer 6~7.5mg (potency)/kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Neonates (less than 1 week old): Administer 4mg (potency)/kg of body weight per day in divided doses every 12 hours. For children, reduce the volume of diluent proportionally.

Precautions

This medication may allow glass particles to enter when the injection container is opened; therefore, care must be taken not to introduce any glass particles. Extra caution is necessary for children and the elderly. This drug should not be administered to patients with known allergies to it, patients with specific ear diseases, severe renal impairment, those who are pregnant or nursing, patients with muscular disorders, patients with asthma, and patients with neurological disorders. Patients with reduced kidney or liver function, newborns or premature infants, the elderly, and those with poor nutritional status should be particularly cautious when using this medication, and any signs of an allergic reaction should be closely monitored. Rarely, using this medication may result in shock, indigestion, blood abnormalities, dizziness, tinnitus, hearing loss, liver dysfunction, kidney damage, skin rash, allergic reactions, vitamin deficiency symptoms, and injection site pain. If any unusual symptoms occur, use should be immediately discontinued, and medical attention should be sought. To prevent the emergence of resistant strains, it is important to confirm susceptibility to the infecting bacteria and use this medication for the minimum required duration. To prevent hearing impairment and deterioration of kidney function, it is advisable to limit the duration of administration to 10 days. Regularly monitoring blood drug concentrations is crucial to ensure levels do not become excessively high or low, especially in patients with compromised renal function, the elderly, or those on prolonged treatment. Patients with specific genetic mutations may have an increased risk of permanent hearing loss from this medication, and alternative treatments may need to be considered in such cases. This medication should not be used with other drugs that place strain on the kidneys, and caution is needed when used concurrently with anesthetics or muscle relaxants due to the risk of respiratory depression. During pregnancy, it may cause hearing damage to the fetus, so administration should only occur when absolutely necessary, whereas breastfeeding mothers should discontinue breastfeeding while taking this medication as it can be passed into breast milk. Newborns or low birth weight infants have immature renal function potentially leading to prolonged drug retention in the body, necessitating careful adjustment of dosing intervals. The elderly are at a higher risk of drug accumulation due to decreased renal function, which may lead to side effects, requiring adjustment of dosage and monitoring of their status. In the event of overdose, kidney damage, hearing and vestibular dysfunction, muscle paralysis, and respiratory failure may occur, requiring immediate hospital treatment such as hemodialysis. This medication's efficacy may diminish if mixed with beta-lactam antibiotics; accordingly, they should be administered through different routes. Caution is warranted when administering this medication to patients who have undergone massive blood transfusions, as it may result in neuromuscular blockade and respiratory paralysis. Lastly, some bacteria resistant to this medication have been reported, so usage should be in accordance with medical personnel's directions.

Side effects

  • Shock
  • nausea
  • vomiting
  • loss of appetite
  • stomatitis
  • diarrhea
  • anemia
  • leukopenia
  • leukocytosis
  • granulocytosis
Show 52 more
  • eosinophilia
  • thrombocytopenia
  • dizziness
  • tinnitus
  • hearing loss
  • otalgia
  • ear fullness
  • lip numbness
  • limb numbness
  • drowsiness
  • headache
  • somnolence
  • confusion
  • local loss of sensation
  • heaviness
  • incoherence
  • loss of directional sense
  • increased ALT
  • increased AST
  • elevated serum LDH
  • increased bilirubin
  • liver dysfunction
  • jaundice
  • acute renal failure
  • edema
  • elevated BUN
  • elevated NPN
  • increased serum creatinine
  • oliguria
  • proteinuria
  • hematuria
  • electrolyte abnormalities
  • exfoliative dermatitis
  • toxic epidermal necrolysis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • rash
  • urticaria
  • itching
  • erythema
  • fever
  • symptoms of vitamin K deficiency
  • hypoprothrombinemia
  • bleeding tendency
  • symptoms of vitamin B deficiency
  • glossitis
  • neuritis
  • injection site pain
  • injection site induration
  • injection site inflammation
  • phlebitis
  • overgrowth of resistant bacteria

Not everyone experiences these, and they can vary from person to person.

Storage

To protect this medication from air and moisture, it should be stored in a sealed container at a temperature between 1 degree and 30 degrees Celsius. Proper storage can help maintain the efficacy of the medication over time.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a colorless transparent ampoule

Package unit

2mL-50 ampoules per box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.